Compare D R Horton Inc (DHI) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D R Horton Inc vs Tenet Healthcare Corporation — how do they compare? D R Horton Inc trades at $135.82 (market cap $37.28B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: D R Horton Inc is the larger of the two by market cap, and D R Horton Inc pays a 1.35% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold D R Horton Inc for 46 Days and Tenet Healthcare Corporation for 15 Days on average.
| DHI | THC | |
|---|---|---|
Market Cap | $37.28B | $20.92B |
Volume | 3,571,611 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $167.78 | $280.77 |
52-Week Low | $132.53 | $161.37 |
Typical Hold Time | 46 Days | 15 Days |
Enterprise Value | $42.38B | $32.00B |
Dividend Yield | 1.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
D.R. Horton (DHI) trades at $135.82, down 0.68% amid broader housing sector pressure from rising mortgage rates. The stock shows bearish technical signals with oversold RSI readings, while fundamentals remain solid with consistent earnings beats and attractive valuation at 12.71 P/E. Recent news highlights sector-wide challenges as mortgage rates approach 7%, though the company maintains strong cash flow generation and dividend payments.
Despite near-term headwinds from rising rates, DHI's strong market position, consistent execution, and discounted valuation present opportunity for long-term investors. Key risks include prolonged housing market weakness and further rate hikes, but analyst consensus remains positive with $156.57 price target suggesting 15% upside potential from current levels.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About D R Horton Inc
D.R. Horton is a leading homebuilder in the United States with operations in 98 markets across 31 states. D.R. Horton mainly builds single-family detached homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
Read more on DHI →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
